The Ensign Group (NASDAQ:ENSG) Price Target Cut to $202.00 by Analysts at Truist Financial

The Ensign Group (NASDAQ:ENSG) had its price objective reduced by Truist Financial from $215.00 to $202.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Truist Financial’s target price indicates a potential upside of 22.76% from the stock’s previous close.

Other analysts also recently issued reports about the stock. Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Weiss Ratings cut The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of The Ensign Group in a research report on Tuesday, June 9th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, The Ensign Group presently has a consensus rating of “Moderate Buy” and an average price target of $213.50.

The Ensign Group Stock Down 2.3%

NASDAQ ENSG opened at $164.55 on Tuesday. The Ensign Group has a 52 week low of $134.79 and a 52 week high of $218.00. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $9.62 billion, a P/E ratio of 26.86, a price-to-earnings-growth ratio of 1.65 and a beta of 0.69. The stock’s 50-day moving average price is $166.24 and its 200-day moving average price is $184.27.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The company had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period in the prior year, the firm posted $1.52 EPS. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. On average, equities research analysts predict that The Ensign Group will post 6.82 earnings per share for the current year.

Insider Activity at The Ensign Group

In related news, Director John O. Agwunobi sold 392 shares of the firm’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $199.97, for a total value of $78,388.24. Following the completion of the transaction, the director directly owned 9,295 shares of the company’s stock, valued at approximately $1,858,721.15. This trade represents a 4.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the sale, the director owned 21,352 shares in the company, valued at approximately $3,507,706.56. This trade represents a 3.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,892 shares of company stock valued at $340,591 in the last 90 days. 4.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On The Ensign Group

Institutional investors and hedge funds have recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of The Ensign Group by 9.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after acquiring an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after purchasing an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of The Ensign Group by 65.9% in the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock worth $83,000 after buying an additional 213 shares during the last quarter. Amundi lifted its stake in shares of The Ensign Group by 480,216.7% during the second quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares during the period. Finally, Brown Advisory Inc. grew its holdings in shares of The Ensign Group by 26.1% during the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after buying an additional 421 shares during the last quarter. 96.12% of the stock is owned by hedge funds and other institutional investors.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.